Medical Properties Trust (MPW) Financials
$4.63
As on 02-Apr-2026 09:30EDT
Market cap
$3,020 Mln
Revenue (TTM)
$1,000 Mln
P/E Ratio
--
P/B Ratio
0.6
Div. Yield
6.3 %
Income Statement ($ Mln) |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
1,000.29
|
972.02
|
995.55
|
871.80
|
1,542.85
|
1,544.67
|
|||||
|
Cost of Revenue
|
163.09
|
36.42
|
27.26
|
41.57
|
45.70
|
39.10
|
|||||
|
Gross Profit
|
585.13
|
935.61
|
968.29
|
830.23
|
1,497.15
|
1,505.57
|
|||||
|
Operating Expenses
|
897.74
|
972.02
|
581.45
|
748.95
|
493.47
|
466.89
|
|||||
|
Operating Profit (EBIT)
|
429.49
|
539.78
|
386.85
|
81.28
|
1,003.68
|
1,038.68
|
|||||
|
Other Income
|
--
|
--
|
--
|
--
|
315.07
|
59.60
|
|||||
|
Profit before Tax
|
-128.46
|
-237.32
|
-2,364.19
|
-686.77
|
959.72
|
730.89
|
|||||
|
Provision for Tax
|
-15.23
|
-38.62
|
44.10
|
-130.68
|
55.90
|
73.95
|
|||||
|
Profit after Tax (Net Income)
|
-112.96
|
-198.70
|
-2,410.27
|
-556.48
|
902.60
|
656.02
|
|||||
|
Minority Interest
|
-0.85
|
-1.11
|
-1.98
|
-0.29
|
-1.22
|
-0.92
|
|||||
|
Consolidated Profit
|
-176.57
|
--
|
-2,411.22
|
-558.12
|
901.00
|
656.02
|
Liabilities ($ Mln) |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
4,544.71
|
4,607.64
|
4,832.73
|
7,631.60
|
8,592.84
|
8,445.67
|
|||||
|
Minority Interest
|
-0.85
|
--
|
--
|
--
|
1.57
|
5.48
|
|||||
|
Non-Current Liabilities
|
10,095.82
|
10,246.55
|
8,615.43
|
8,706.42
|
9,484.96
|
11,440.78
|
|||||
|
Current Liabilities
|
121.09
|
147.59
|
845.38
|
1,964.56
|
1,578.64
|
633.36
|
|||||
|
Total Liabilities
|
14,883.77
|
15,001.78
|
14,294.59
|
18,304.84
|
19,658.00
|
20,519.80
|
Assets ($ Mln) |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
12,109.74
|
872.37
|
12,980.88
|
16,907.46
|
17,935.78
|
17,947.17
|
|||||
|
Current Assets
|
1,347.06
|
1,441.52
|
1,313.71
|
1,397.39
|
1,722.22
|
2,572.63
|
|||||
|
Total Assets
|
16,109.73
|
15,001.78
|
14,294.59
|
18,304.84
|
19,658.00
|
20,519.80
|
|||||
|
Total Debt*
|
102.51
|
128.30
|
8,977.16
|
10,220.84
|
10,414.54
|
12,882.38
|
|||||
|
Net Current Assets
|
--
|
609.38
|
468.33
|
-567.17
|
768.66
|
1,939.28
|
Cashflow ($ Mln) |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
230.77
|
245.48
|
505.79
|
739.01
|
811.66
|
|||||
|
Cash Flow from Investing Activities
|
--
|
-264.74
|
1,318.34
|
517.56
|
396.06
|
-3,858.41
|
|||||
|
Cash from Financing Activities
|
--
|
228.08
|
-1,479.38
|
-1,020.33
|
-1,342.52
|
2,947.61
|
|||||
|
Net Cash Inflow / Outflow
|
--
|
--
|
--
|
--
|
-207.46
|
-99.15
|
Financials Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS ($)
|
-0.19
|
-0.33
|
-4.01
|
-0.93
|
1.51
|
1.10
|
|||||
|
Cash EPS ($)
|
--
|
0.12
|
-3.26
|
0.11
|
2.07
|
1.64
|
|||||
|
Adjusted Book Value ($)
|
--
|
7.67
|
8.05
|
12.74
|
14.37
|
14.15
|
|||||
|
Dividend per Share ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cash Flow per Share ($)
|
--
|
0.38
|
0.41
|
0.84
|
1.24
|
1.36
|
|||||
|
Free Cash Flow per Share ($)
|
--
|
0.38
|
0.41
|
0.84
|
1.24
|
1.25
|
Profitability Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
-2.14
|
-15.22
|
-3.02
|
4.48
|
3.48
|
|||||
|
ROE (%)
|
-2.47
|
-4.21
|
-38.67
|
-6.86
|
10.59
|
8.31
|
|||||
|
ROA (%)
|
-0.70
|
-1.36
|
-14.79
|
-2.93
|
4.49
|
3.51
|
|||||
|
EBIT Margin (%)
|
34.18
|
-24.41
|
38.86
|
9.32
|
65.05
|
67.24
|
|||||
|
Net Margin (%)
|
-11.29
|
-20.44
|
-242.11
|
-63.83
|
48.58
|
40.89
|
|||||
|
Cash Profit Margin (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
Growth Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
5.13
|
-0.02
|
0.14
|
-0.43
|
0.00
|
0.24
|
|||||
|
EBIT Growth (%)
|
145.58
|
-161.35
|
375.92
|
-91.90
|
-3.37
|
25.38
|
|||||
|
Net Profit Growth (%)
|
93.12
|
91.76
|
-333.13
|
-161.65
|
37.59
|
52.05
|
|||||
|
EPS Growth (%)
|
93.16
|
0.92
|
-3.32
|
-1.62
|
0.37
|
0.37
|
|||||
|
Book Value Growth (%)
|
-4.08
|
--
|
--
|
--
|
--
|
--
|
Valuation Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
--
|
-15.12
|
-0.98
|
-5.29
|
7.38
|
21.49
|
|||||
|
Price / Book Value
|
0.60
|
0.65
|
0.49
|
0.39
|
0.78
|
1.67
|
|||||
|
Dividend Yield (%)
|
6.34
|
--
|
--
|
--
|
--
|
--
|
|||||
|
EV/EBITDA
|
14.83
|
92.30
|
13.11
|
18.45
|
11.23
|
17.83
|
|||||
|
Close Price ($)
|
4.63
|
5.00
|
3.95
|
4.91
|
11.14
|
23.63
|
|||||
|
High Price ($)
|
6.09
|
6.34
|
6.55
|
14.00
|
24.13
|
23.74
|
|||||
|
Low Price ($)
|
3.95
|
3.51
|
2.92
|
4.04
|
9.90
|
19.39
|
|||||
|
Market Cap ($ Cr)
|
3,019.53
|
--
|
--
|
--
|
--
|
--
|
Solvency Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
--
|
0.03
|
1.86
|
1.34
|
1.21
|
1.53
|
|||||
|
Short term debt to equity ratio
|
0.02
|
0.03
|
0.07
|
0.20
|
0.11
|
0.19
|
|||||
|
Current Ratio
|
11.12
|
9.77
|
1.55
|
0.71
|
1.09
|
4.06
|
|||||
|
Quick Ratio
|
11.12
|
--
|
--
|
0.79
|
1.28
|
2.10
|
|||||
|
Interest Coverage
|
0.66
|
--
|
0.92
|
0.20
|
2.72
|
2.63
|
Operating Efficiency Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
92.18
|
92.66
|
85.01
|
111.68
|
76.61
|
136.82
|
|||||
|
Asset Turnover
|
0.06
|
0.07
|
0.06
|
0.05
|
0.08
|
0.08
|
|||||
|
Receivable days
|
--
|
328.22
|
333.85
|
451.58
|
390.08
|
414.80
|
|||||
|
Inventory Days
|
--
|
--
|
-2,003.04
|
-1,994.58
|
3,754.50
|
5,810.57
|
|||||
|
Payable days
|
--
|
4,555.81
|
5,805.32
|
4,540.70
|
4,895.29
|
4,629.11
|
|||||
|
Cash Conversion Cycle
|
--
|
--
|
-7,474.50
|
-6,083.70
|
-750.72
|
1,596.25
|